Symbiotec Pharmalab trades higher on the BSE
Symbiotec Pharmalab is currently trading at Rs. 1116.90, up by 60.15 points or 5.69% from its previous closing of Rs. 1056.75 on the BSE.
The scrip opened at Rs. 1043.10 and has touched a high and low of Rs. 1135.05 and Rs. 1043.10 respectively. So far 119536 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 1193.90 on 10-Sep-2026 and a 52 week low of Rs. 933.80 on 01-Sep-2026.
Last one week high and low of the scrip stood at Rs. 1,145.45 and Rs. 986.35 respectively. The current market cap of the company is Rs. 7127.93 crore.
The promoters holding in the company stood at 33.28%, while Institutions and Non-Institutions held 47.47% and 19.25% respectively.
Symbiotec Pharmalab has received the establishment inspection report (EIR) from the U.S. Food and Drug Administration (USFDA) for its manufacturing facility in Pithampur (SEZ), Madhya Pradesh India with a Voluntary Action Indicated (VAI) status. The inspection was conducted at the company’s manufacturing facility at Pithampur, from August 10, 2026 to August 14, 2026.
